FDG-PET/CT in re-staging of patients with lymphoma.
作者： L. S. Freudenberg , G. Antoch , P. Sch�tt , T. Beyer , W. Jentzen
DOI: 10.1007/S00259-003-1375-Y
关键词: Fdg pet ct 、 Lymphoma 、 Computed tomography 、 PET-CT 、 Nuclear medicine 、 Clinical significance 、 Regional lymph node involvement 、 Radiology 、 Fluorodeoxyglucose positron emission tomography 、 In patient 、 Medicine
摘要: The aim of this study was to evaluate the clinical significance combined fluorine-18 fluorodeoxyglucose positron emission tomography and computed (FDG-PET/CT) in patients with lymphoma, compare FDG-PET/CT staging results those FDG-PET CT alone. Twenty-seven were studied. Each patient had follow-up for >12 months entered complete evaluation. Patient-based evaluation showed a sensitivity 78% alone, 86% 93% read side by side, imaging. Region-based regional lymph node involvement 61%, 78%, 91% 96% respectively. imaging is superior alone (P=0.02) has additional benefit over due exact anatomical localisation. We conclude that accurate re-staging lymphoma offers advantages separate
springer.com
sci-hub.se 参考文章(28)
Beyer T, Townsend Dw, Blodgett Tm, Dual-modality PET/CT tomography for clinical oncology. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine. ,vol. 46, pp. 24- 34 ,(2002)
Stephen I. Schabel, Computed tomography of abdominal paraaortic lymph node disease: preliminary observations with a 6 second scanner:Marshall WH Jr, Breiman RS, Harell GS, Glatstein E, Kaplan HS (Stanford University School of Medicine, Stanford, California) Am J Roentgenol 128:759–764, May 1977 Journal of Computed Tomography. ,vol. 1, pp. 157- ,(1977) , 10.1016/0149-936X(77)90028-5
Peter S. Conti, Ludwig G. Strauss, The Applications of PET in Clinical Oncology The Journal of Nuclear Medicine. ,vol. 32, pp. 623- 648 ,(1991)
J A Radford, R A Cowan, M Flanagan, G Dunn, D Crowther, R J Johnson, B Eddleston, The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. Journal of Clinical Oncology. ,vol. 6, pp. 940- 946 ,(1988) , 10.1200/JCO.1988.6.6.940
Ichiei Kuji, Lale Kostakoglu, Stanley J. Goldsmith, Morton Coleman, John P. Leonard, Holly Zoe, PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin’s Disease The Journal of Nuclear Medicine. ,vol. 43, pp. 1018- 1027 ,(2002)
M Janicek, W Kaplan, D Neuberg, G P Canellos, L N Shulman, M A Shipp, Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 1631- 1637 ,(1997) , 10.1200/JCO.1997.15.4.1631
Johannes Czernin, Sanjiv S. Gambhir, Judy Schwimmer, Michael E. Phelps, R. Edward Coleman, Daniel H. S. Silverman, A Tabulated Summary of the FDG PET Literature The Journal of Nuclear Medicine. ,vol. 42, pp. 441- 441 ,(2001)
N.G. Mikhaeel, A.R. Timothy, S.F. Hain, M.J. O'Doherty, 18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas Annals of Oncology. ,vol. 11, pp. 147- 150 ,(2000) , 10.1093/ANNONC/11.SUPPL_1.S147
K. Spaepen, S. Stroobants, P. Dupont, P. Vandenberghe, J. Thomas, T. de Groot, J. Balzarini, C. De Wolf-Peeters, L. Mortelmans, G. Verhoef, Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma Annals of Oncology. ,vol. 13, pp. 1356- 1363 ,(2002) , 10.1093/ANNONC/MDF256
U. CREMERIUS, U. FABRY, J. NEUERBURG, M. ZIMNY, R. OSIEKA, U. BUELL, Positron emission tomography with 18f-fdg to detect residual disease after therapy for malignant lymphoma Nuclear Medicine Communications. ,vol. 19, pp. 1055- 1063 ,(1998) , 10.1097/00006231-199811000-00005